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A broad range of skeletal imaging techniques have been developed to aid our understanding of skeletal mass, size and architecture and engineering models such as finite element analysis have been applied to determine bone strength. DXA remains the gold-standard clinical means of assessing skeletal parameters [8, 9] , although challenges in interpreting DXA in relation to body size and proportions [10] , particularly in obese children [2] , and tissue thickness and distribution in [11, 12] have called into question the accuracy of assessing bone mass and density in relation to increasing adiposity. At the limits of in vivo scanning resolutions, HR-pQCT provides a detailed view of trabecular and cortical microarchitecture but is limited to the distal extremities and may not reflect skeletal changes elsewhere in the skeleton. In this Special Edition, the clinical considerations and diagnostic challenges in relation to skeletal imaging of children are reviewed. The challenge ahead is the development of a scanning technique that provides an accurate assessment of skeletal microarchitecture in the appendicular and axial skeleton relevant to changes in factors affecting the skeleton such as hormonal changes and physical activity in children and adults.
The discovery of hormones produced almost exclusively by adipose tissue led to a focus on the interaction between adipocytes and bone cells that may in part help to explain the clinical observations. However, results between studies can be conflicting and thus in vitro and animal in vivo findings may not always be relevant to humans. Our For decades there has been a debate about the impact of adiposity on the skeleton and we have by no means reached a conclusion. This exciting area has moved forward considerably, in part driven by a profound increase in the prevalence of obesity and osteoporosis. Initial clinical observations and studies with DXA suggested that obesity was osteoprotective, at least in adults [1, 2] . More recently it has been suggested that obese adults are more prone to fracture which may be confined to specific skeletal regions [3] . However, the increased risk of fracture in obese children implied that the impact of obesity on bone was agedependent. This led to a number of studies examining the relationship between childhood obesity and bone with conflicting results, with some suggesting a positive relationship between adiposity and bone with others suggesting that excess fat is detrimental to the developing skeleton [2] . The issue of 'obesity' and the effect on the developing and adult skeleton was perhaps considered overly simplistic and subsequent work focusing on fat distribution demonstrated that, as with other metabolic conditions, it is visceral fat that appears to have a deleterious effect on the skeleton [4, 5] although again not all studies in adults are in agreement with this [3] . The advent of high resolution pQCT (HRpQCT) has allowed us to examine the in-vivo relationship between fat and bone at a microstructural level in children with results demonstrating that the trabecular architecture understanding of how adipokines affect and control energy regulation resulted in a shift from initial in vitro findings attempting to elucidate the direct and systemic effects of adipokines on skeletal cells, to determine how key areas of the brain such as the hypothalamus may control the skeleton. Starting with leptin at the turn of the century [13] , the number of central mediators of bone metabolism has grown significantly and their roles now extended to controlling bone homeostasis rather than simply exerting a positive or negative effect on bone. Our understanding of neuronal control has extended from the sympathetic nervous system [14] to the parasympathetic and sensory nervous systems [15, 16] . Abnormalities in the central nervous system such as vestibular dysfunction may also indirectly affect bone mass [17] . The role of the central nervous system in bone metabolism and the specific role of adiponectin in skeletal metabolism are addressed in this issue. Moving towards the skeletal microenvironment, metabolically active marrow adipose tissue has the potential to influence and control local processes [18] and may also contribute to the development of disease such as myeloma [19] . In this issue, McDonald et al. provide a comprehensive review on how cells in the bone microenvironment including adipocytes contribute to the origin of multiple myeloma, and the subsequent disease progression and drug resistance. They proposed several potential therapeutic approaches to prevent tumour progression whilst inducing bone regeneration. The paper by Craft and Scheller supports the wider view that fat cells and depots in the marrow tissue microenvironment have the potential to control multiple aspects of the skeletal metabolism, albeit that marrow adipose and white adipose tissues appear to have distinct phenotypes and evolutionary origins. The ever-intriguing, complex and rapidly emerging relationships between fat and bone from a cellular to clinical level inspired us to bring together experts in the field to provide a series of commissioned reviews summarizing the latest advances. One of the greatest challenges is the translation of current knowledge into relevant clinical applications. Importantly, this special 'fat and bone' edition of Calcified Tissue International highlights areas that require further work to enhance our understanding of fat-bone relationships on a background of many other factors that influence skeletal metabolism.
